infested with Trichomonas vaginalis (Rodin, King, Nicol, and Barrow, 1960) . This paper describes the first stage of an investigation designed to determine, in the first instance, the general absorption and excretion pattern of the drug and, secondly, the cause of failure in the remaining 10 per cent. Failure to eradicate the parasite could be due to:
(1) Failure of the patient to take the drug; (2) Failure of the patient to absorb the drug; (3) Resistance of the parasite to the drug; (4) Failure of the drug, having been absorbed satisfactorily, to reach the parasite; (5) Re-infection. The investigations to be described concern points (2) and (3). The initial part of the investigation was an attempt to establish a normal pattern of absorption and excretion following the administration of a single tablet (200 mg.) 
27
were taken, in order to establish the absence of substances which could interfere with subsequent metronidazole determination. 200 mg. metronidazole were then administered orally; further blood samples were taken at 1, 2, 4, 8, and 24 hrs and the serum was assayed by the polarographic method (Kane, 1961) , which gives comparable results to bioassay and is much quicker (Rodin and others, 1960) . Urine was collected at 2 hrs, 4 hrs, and thereafter as passed, and the bladder was finally emptied at 24 hrs. The volumes were measured and again an assay of metronidazole was made on each sample by the polarographic method. These patients were then treated with the standard course of therapy and the response recorded.
One other patient was admitted to hospital for 24 hrs to follow the absorption and excretion during normal daily therapy of 3 x 200 mg. tablets, and estimations were made on two further in-patients while they were receiving the standard course of 200 mg. tablets three times daily for 7 days. Results Trichomonads were successfully grown in nine out of the twelve cultures taken from the patients admitted to hospital for 24 hrs and all showed normal sensitivity to metronidazole (0 * 25-1 ,ug./ml.).
No interfering substance was found in the baseline samples examined by polarography. 
1-2 4-2 14-1 9.9 7-5 9.0 3-5 13-0 7-0 7-5 9-2 8-0 3-1 2-4 3-8 13-0 10-8 9-6 13-3 6 5 16-0 10-2 20-8 The urinary excretion values are shown in Table II . There were wide variations from patient to patient, the total excretion over 24 hrs ranging from 13 to 58 per cent. of the drug administered.
These twelve patients were then given the standard course of therapy (200 mg. three times daily for 7 days), at the end of which vaginal smears and cultures were made from eleven patients, the twelfth having failed to report back. Of these eleven, ten were negative and remained so. Smears and cultures from the eleventh patient were negative for 8 to 9 weeks after treatment, after which trichomonads were again found in the vagina. These showed normal sensitivity to metronidazole in culture and it seems likely that this was a re-infection.
The estimations on the sera of these twelve patients were considered to be sufficient to give a normal standard, particularly in view of the fact that the results were so consistent and the response to therapy uniformly good.
The one patient from whom samples of serum and urine were obtained after the daily therapeutic course of three 200-mg. tablets showed a normal absorption pattern at 1 hr (Table II1) , and the peak serum concentration rose to 8 ,ug./ml. at the end of 8 hrs, i.e. 4 hrs after the second dose. The serum concentration in this patient was still 3 6 ,ug./mI. after 24 hrs, at which time approximately 30 per cent. of the total drug ingested had been recovered in the urine. Two further patients were given the standard therapeutic course of treatment (one 200-mg. tablet three times daily for 7 days) and the serum concentrations were followed as well as the urinary output. The results are given in Table IV (opposite). There was no evidence of accumulation of the drug in the serum over 7 days. In both cases the urinary excretion over the first 24 hrs was approximately the same, i.e. 50 per cent. of the drug ingested; after this, however, there was a wide variation in the urinary The urinary excretion rate appeared variable from patient to patient and it was found that after a single dose, 13-58 per cent. of the total drug was excreted within 24 hrs. In two patients, when the excretion of the drug was followed for the whole of a standard course of therapy of 200 mg. three times daily for 7 days, a marked variation in the rate of excretion was seen, although serum concentrations taken at comparable times were closely related. There was no evidence of accumulation of the drug in the serum.
